🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate efficacy and safety of brigatinib ...
Status
Completed
Location
Aichi Cancer Center Hospital
Start Date
2018-01-29
Trial ID
NCT03410108
Treatments Being Tested
FDA approved drugs to treat patients with relapsed or refractory anaplastic...
Status
Withdrawn
Location
Fox Chase Cancer Center
Start Date
2018-12-06
Trial ID
NCT03719898
Treatments Being Tested
This is a phase II randomized, open-labelled, non-comparative multicenter s...
Status
Active Not Recruiting
Location
CHU d'Angers
Start Date
2022-05-18
Trial ID
NCT05200481
Treatments Being Tested
Brigatinib is a medicine that binds to the surface of tumor cells in some c...
Status
Completed
Location
The Oncology Institute of Hope and Innovation
Start Date
2019-04-19
Trial ID
NCT03596866
Treatments Being Tested
This is a multi-arm phase II platform-basket screening study designed to te...
Status
Recruiting
Location
UCLA Medical Center
Start Date
2020-06-20
Trial ID
NCT04374305
Treatments Being Tested
This phase II trial studies how well brigatinib works in treating patients ...
Status
Withdrawn
Location
Ohio State University Comprehensive Cancer Center
Start Date
2019-03-20
Trial ID
NCT03868423
This is a single-arm clinical study planning to enroll 30 treatment-naive p...
Status
Not Yet Recruiting
Location
Fuzhou Pulmonary Hospital
Start Date
2026-08-01
Trial ID
NCT07771764
Treatments Being Tested
This is an open-label, non-randomised, phase II, exploratory, multi-country...
Status
Active Not Recruiting
Location
Complejo Hospitalario de A Coruña
Start Date
2020-05-04
Trial ID
NCT04223596
Treatments Being Tested
This study is a survey in Japan of Brigatinib tablets used to treat Japanes...
Status
Recruiting
Location
Takeda Selected Site
Start Date
2021-11-01
Trial ID
NCT05100069
Treatments Being Tested
The primary purpose of this study is to determine the efficacy of brigatini...
Status
Completed
Location
University of California Irvine Health Chao Family Comprehensive Cancer Center
Start Date
2019-01-31
Trial ID
NCT03535740
Treatments Being Tested